1 in 8 couples who desire children either cannot conceive or carry a baby to term. Of these, only 15% will seek help from specialized clinics due to financial, geographic, and outcome limitations. Our Web-based platforms empower primary care providers to diagnose and treat their infertile patients, and to allow infertile patients to follow their journey with detailed explanations of each and every step. They were built using a protocol (co-owned by the University of Illinois) developed and refined over 30 years of clinical practice. Alpha testing demonstrated our approach optimizes the use of scientific expertise while eliminating both inconvenience and human error. Success rates are increased over conventional treatment while costs are dramatically reduced. Our customers are primary care providers and their infertile patients, healthcare networks, and third party payers. Our medical team includes Fertility Specialists and Primary Care Providers backed by a mature business team with extensive C-level experience. Beginning in 1st quarter 2022, we will beta test our products under Institutional Review Board (IRB) and Food and Drug Administration (FDA) oversight. Our go-to-market target date is 1st quarter 2023. We have already identified our first customer: A 15-Hospital network headquartered in Illinois.
Ready to Ask For Funding for your company?
Post a Funding Request